On the other hand, by siRNA screening, we observed that knocking down any of these genes did not change the sensitivity of TRCs to RSL3, whereas knocking down of ACSL4 or LPCAT3 significantly decreased the sensitivity of cells to RSL3 in bulk tumor cells (Supplementary Fig. 2c–j). The gene discussed is ACSL4; the disease is neoplasm.